Nov 28 (Reuters) - Timber Pharmaceuticals Inc TMBR.A :
* TIMBER PHARMACEUTICALS RECEIVES COURT APPROVAL OF ALL
“FIRST
DAY” MOTIONS TO SUPPORT BUSINESS OPERATIONS & DISCLOSES
COMMUNICATION FROM NYSE AMERICAN
* TIMBER PHARMACEUTICALS INC- HAS RECEIVED $3.0 MILLION OF
NEW
MONEY DIP FUNDING
* TIMBER PHARMACEUTICALS INC- DIP FINANCING IS BEING
PROVIDED BY
LEO US HOLDING, INC., AS LENDER
* TIMBER PHARMACEUTICALS: RECEIVED AUTHORIZATION TO CONTINUE
TO
PAY VENDORS IN ORDINARY COURSE FOR GOODS AND SERVICES PROVIDED
ON A POST-PETITION BASIS
* TIMBER PHARMACEUTICALS INC: RECEIVED AUTHORIZATION TO
CONTINUE
TO PAY EMPLOYEE WAGES, PROVIDE HEALTHCARE AND OTHER BENEFITS
* TIMBER PHARMACEUTICALS- PHASE 3 ASCEND STUDY WILL PROGRESS
WHEN
CO PURSUES SALE OF MOST OF ITS ASSETS TO "STALKING HORSE" BIDDER
AFFILIATED WITH LEO
Source text for Eikon: ID:nGNXTV1Wh
Further company coverage: TMBR.A
((Reuters.Briefs@thomsonreuters.com;))